Colombia sets Kaletra price ceiling
This article was originally published in Scrip
Executive Summary
The Colombian government has set a maximum price for Abbott's Kaletra (lopinavir plus ritonavir), reducing the private sector price by around 55%. However, civil society is still pushing for the government to issue a compulsory licence.